Addyi (Flibanserin) Safety Profile in Hispanic and Latino Patients
Evidence-based review of flibanserin safety differences in Hispanic and Latino populations, including CYP enzyme pharmacogenomics, metabolic considerations, and clinical trial subgroup data.
Read clinical review